Pfizer Ownership
| PFE Stock | EUR 24.57 0.13 0.53% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Pfizer |
Pfizer Stock Ownership Analysis
About 71.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 17.03. The company has Price/Earnings To Growth (PEG) ratio of 1.19. Pfizer Inc recorded earning per share (EPS) of 5.16. The entity last dividend was issued on the 26th of January 2023. Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 92400 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.Pfizer Outstanding Bonds
Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PFIZER INC 4125 Corp BondUS717081ED10 | View | |
| PFIZER INC 4 Corp BondUS717081EC37 | View | |
| PFIZER INC 3 Corp BondUS717081EA70 | View | |
| PFIZER INC 44 Corp BondUS717081DK61 | View | |
| PFIZER INC 275 Corp BondUS717081DV27 | View | |
| US717081DT70 Corp BondUS717081DT70 | View | |
| PFIZER INC Corp BondUS717081EZ22 | View | |
| PFE 175 18 AUG 31 Corp BondUS717081FB45 | View |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Pfizer Stock
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.